Jin David — SEC Form 4 filings
SEC reporting owner CIK 1930732. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-04-02 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 747 shares, $3,988 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 500 shares @ $7.50 ($3,750) in Fortress Biotech, Inc., filed 2024-07-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | Chief Financial Officer | 8 | 1 leg · 500 sh · $3,750 | — | 7 |
| MUSTANG BIO, INC. (MBIO) | Director | 1 | 1 leg · 247 sh · $238 | — | — |
| AVENUE THERAPEUTICS, INC. (ATXI) | Interim PFO and COO | 1 | — | — | 1 |
Form 4 filings — Jin David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-04-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,967 @ $2.18 | EDGAR |
| 2025-12-30 | 4 | MUSTANG BIO, INC. (MBIO) | Purchase (P): 247 @ $0.96 | EDGAR |
| 2025-10-02 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,711 @ $1.31 | EDGAR |
| 2025-04-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 5,000 @ $1.22 | EDGAR |
| 2024-12-23 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2024-10-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,625 @ $1.23 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2024-07-12 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 500 @ $7.50 | EDGAR |
| 2024-04-02 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,352 @ $1.70 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1930732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →